Count on Actum to seamlessly complement your team, adding guidance, grit and guardrails on your way to Market success
The Problem We Solve
The risk of failure to R&D companies is high. According to an article published by McKinsey on February 15, 2023 titled “Making the leap from R&D to fully integrated biotech for first launch,” only 28% of first-time launches exceed analysts’ forecasts.
For these R&D companies, early success is crucial. Around 86% of successful launches continued to meet or beat expectations in years 2 and 3. The real game changer is operational preparedness. Successful launches build 5 key functions 1-6 months sooner than unsuccessful launches. These 5 key functions are:
Capital/financial management
Medical Affairs
Commercial
Patient Advocacy
Market Access
Patient Support
The Actum Solution
The specialty pharmaceutical ecosystem is complex and ever-changing. Actum Pharma has the expertise and tools to help you navigate a successful path to commercialization.
Along key inflection points, Actum will not only get ahead of critical milestones that lie head, but demonstrate readiness in a way that increases company valuation with investors.
From market access and early planning, to launch and beyond, we will help you develop and manage a custom program to meet your specific needs, so your therapy can get to the patients who need it most.
Who We Work With
BIOPHARMA C-SUITE LEADERS
We work with biopharma leaders who are looking to strengthen and reinforce asset value across all stages of the product lifecycle – prelaunch through mature therapies. Our primary relationships are typically with C-suite leaders with broad purview over their organization, looking to reinforce and strengthen their plans and teams on the road to creating value.
Chief Executive Officer
Chief Financial Officer
Chief Operating Officer
Chief Commercial Officer
BIOPHARMA FUNCTIONAL BUSINESS LEADERS
Once we complete our Actum Comprehensive Corporate Diagnosis, our team of experts is prepared to seamlessly integrate to support your functional business leads as needed, including:
Finance
Market Access
Operations
Communications
Sales and Marketing
INVESTORS
Actum also works directly with the investor community, strengthening due diligence efforts with our comprehensive Actum Comprehensive Corporate Diagnosis as well as matching high-potential biopharma companies with investment partners.
Managing Partner
Venture Partner
Operating Partner
Principal